Guide for Real-World Evidence
Real-world data (RWD) from electronic medical records, insurance claims, and disease registries have expanded what Biotechs can learn about patient outcomes. Turned into real-world evidence (RWE), this is fast becoming a go-to tool for Biotech companies to optimize asset valuation, inform strategy and support regulator and payer decisions.
Parexel Biotech has created this guide to simplify the nomenclature and types of real-world studies.
Related Insights
Blog
Incorporating the patient voice in clinical research: Validation of COAs for a rare disease NDA
Nov 17, 2025
Blog
Evidence planning for biotechs: Closing gaps to maximize value
Nov 4, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Blog
Investor-ready evidence planning: Why a robust strategy matters to funders
Dec 8, 2025
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Removing barriers through pragmatic clinical trials
Oct 12, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Playbook
Are you using real-world evidence?
Feb 1, 2023
Related Insights
Blog
Incorporating the patient voice in clinical research: Validation of COAs for a rare disease NDA
Nov 17, 2025
Blog
Evidence planning for biotechs: Closing gaps to maximize value
Nov 4, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Blog
Investor-ready evidence planning: Why a robust strategy matters to funders
Dec 8, 2025
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Removing barriers through pragmatic clinical trials
Oct 12, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Playbook
Are you using real-world evidence?
Feb 1, 2023